Efficacy and Treatment Satisfaction of Once-daily Insulin Glargine Plus One or Two Oral Antidiabetic Agents Versus Continuing Premixed Human Insulin in Patients with Type 2 Diabetes Previously on Long-term Conventional Insulin Therapy: The SWITCH Pilot Study-Reference-Cited by-同舟云学术

Efficacy and Treatment Satisfaction of Once-daily Insulin Glargine Plus One or Two Oral Antidiabetic Agents Versus Continuing Premixed Human Insulin in Patients with Type 2 Diabetes Previously on Long-term Conventional Insulin Therapy: The SWITCH Pilot Study

Published:2007-10-31 Issue:01 Volume:116 Page:58-64
ISSN:0947-7349
Container-title:Experimental and Clinical Endocrinology & Diabetes
language:en
Short-container-title:Exp Clin Endocrinol Diabetes

Author:

Schiel R.,Müller U.

Publisher

Georg Thieme Verlag KG

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2007-985367

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Evidence and Practice-Based Guidelines on the Utility of Basal Insulin Combined Oral Therapy (Metformin and Glimepiride) in the Current Era;Current Diabetes Reviews;2023-10

2. Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin;Endocrine Practice;2021-08

3. Efficacy and Safety of Premixed Human Insulin Combined with Sulfonylureas in Type 2 Diabetic Patients Previously Poorly Controlled with Insulin;Diabetes Therapy;2019-01-18

4. Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study;Diabetes Therapy;2017-06-16

5. Personalized intensification of insulin therapy in type 2 diabetes – does a basal–bolus regimen suit all patients?;Current Medical Research and Opinion;2016-05-25